Kobayashi Ken's most recent trade in Pyxis Oncology Inc was a trade of 443,514 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 29, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pyxis Oncology Inc | Kobayashi Ken | Chief Medical Officer | 29 Dec 2023 | 443,514 | 443,514 | - | - | Stock Option (Right to Buy) | ||
Pyxis Oncology Inc | Kobayashi Ken | Chief Medical Officer | 29 Dec 2023 | 110,878 | 110,878 | - | - | Stock Option (Right to Buy) |